8-K Announcements
6Material company update
May 18, 2026·SEC
Material company update
May 14, 2026·SEC
Material company update
May 12, 2026·SEC
InfuSystem Holdings, Inc.(INFU)Earnings, Financials & Key Ratios
INFU•AMEX
30.4× P/E·Price updated Jun 19, 2026
AboutInfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Show more
- Revenue$143M+6.4%
- EBITDA$25M+30.0%
- Net Income$7M+182.6%
- EPS (Diluted)0.31+181.8%
- Gross Margin55.98%+7.2%
- EBITDA Margin17.58%+22.3%
- Operating Margin8.31%+62.6%
- Net Margin4.62%+165.7%
- ROE11.54%+170.2%
INFU Key Insights
InfuSystem Holdings, Inc. (INFU) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong Piotroski F-Score: 8/9
- ✓FCF machine: 16.6% free cash flow margin
- ✓High quality earnings: Operating CF exceeds net income
- ✓Share count reduced 2.8% through buybacks
- ✓Efficient asset utilization: 1.4x turnover
✗Weaknesses
- ✗Profits declining 17.5% over 5 years
- ✗Thin 5Y average net margin of 1.7%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when INFU posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
INFU Price & Volume
InfuSystem Holdings, Inc. (INFU) stock price & volume — 10-year historical chart
Loading chart...
INFU Growth Metrics
InfuSystem Holdings, Inc. (INFU) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years7.12%
5 Years8.05%
3 Years9.28%
TTM3.5%
Profit CAGR
10 Years5.88%
5 Years-17.49%
3 Years616.72%
TTM147.99%
EPS CAGR
10 Years6.84%
5 Years-17.27%
3 Years629.05%
TTM162.63%
Return on Capital
10 Years4.9%
5 Years6.51%
3 Years9.01%
Last Year14.33%
INFU Recent Earnings
InfuSystem Holdings, Inc. (INFU) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.05+25.0%
$0.04
Rev
$34M-1.9%
$34M
Q1 2026
Feb 24, 2026Metric
Actual
Est
EPS
$0.10+42.9%
$0.07
Rev
$36M-1.2%
$37M
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.11+37.5%
$0.08
Rev
$36M-0.5%
$37M
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$0.12+300.0%
$0.03
Rev
$36M-3.7%
$37M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.05vs $0.04+25.0% | $34Mvs $34M-1.9% |
| Q1 2026 | Feb 24, 2026 | $0.10vs $0.07+42.9% | $36Mvs $37M-1.2% |
| Q4 2025 | Nov 4, 2025 | $0.11vs $0.08+37.5% | $36Mvs $37M-0.5% |
| Q3 2025 | Aug 5, 2025 | $0.12vs $0.03+300.0% | $36Mvs $37M-3.7% |
Based on last 12 quarters of dataView full earnings history →
INFU Peer Comparison
InfuSystem Holdings, Inc. (INFU) competitors in Drug delivery and infusion consumables — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 BRT | 280.26M | 14.89 | -22.56 | 1.46% | -12.52% | -6.77% | 2.87 | |
 HCSG | 1.64B | 22.94 | 28.32 | 7.08% | 3.21% | 11.83% | 0.05 | |
 OPRX | 93.45M | 4.98 | 18.44 | 18.78% | 6.37% | 5.47% | 0.20 | |
 ACLX | 6.73B | 115.07 | -28.27 | -79.35% | -10.27% | -55.42% | 0.24 | |
 OMCL | 1.78B | 39.05 | 881.49 | 6.53% | 1.67% | 1.64% | 0.17 | |
 MDXG | 545.24M | 3.67 | 11.47 | 19.99% | 7.88% | 12.86% | 0.09 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 AVNS | 1.17B | 24.94 | -17.08 | 1.95% | -9.69% | -8.91% | 0.17 |
Compare INFU vs Peers
InfuSystem Holdings, Inc. (INFU) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
INFU Income Statement
InfuSystem Holdings, Inc. (INFU) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 71.08M | 67.14M | 81.11M | 97.39M | 102.38M | 109.91M | 125.78M | 134.86M | 143.44M | 142.4M |
Revenue Growth % | 0.82% | -5.54% | 20.82% | 20.06% | 5.13% | 7.36% | 14.44% | 7.22% | 6.36% | 3.5% |
Cost of Goods Sold | 27.72M | 28.12M | 34.23M | 38.63M | 43.85M | 49.35M | 62.68M | 64.46M | 63.14M | 61.59M |
COGS % of Revenue | 38.99% | 41.88% | 42.2% | 39.67% | 42.83% | 44.9% | 49.83% | 47.8% | 44.02% | - |
Gross Profit | 43.36M▲ 0% | 39.02M▼ 10.0% | 46.88M▲ 20.2% | 58.76M▲ 25.3% | 58.54M▼ 0.4% | 60.56M▲ 3.5% | 63.11M▲ 4.2% | 70.4M▲ 11.6% | 80.3M▲ 14.1% | 80.81M▲ 0% |
Gross Margin % | 61.01% | 58.12% | 57.8% | 60.33% | 57.17% | 55.1% | 50.17% | 52.2% | 55.98% | 56.75% |
Gross Profit Growth % | -3.08% | -10.02% | 20.15% | 25.33% | -0.38% | 3.46% | 4.21% | 11.56% | 14.05% | - |
Operating Expenses | 46.18M | 38.6M | 43.36M | 49.93M | 55.72M | 58.91M | 59.02M | 63.51M | 68.38M | 67.92M |
OpEx % of Revenue | 64.97% | 57.5% | 53.45% | 51.27% | 54.42% | 53.59% | 46.92% | 47.09% | 47.67% | - |
Selling, General & Admin | 34.98M | 33.95M | 38.92M | 44.86M | 51.45M | 56.41M | 58.03M | 62.52M | 67.46M | 67.04M |
SG&A % of Revenue | 49.21% | 50.57% | 47.98% | 46.06% | 50.26% | 51.32% | 46.14% | 46.36% | 47.03% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | -113K | -37K | 4.44M | 5.08M | 4.26M | 2.49M | 990K | 991K | 920K | 881K |
Operating Income | -3.81M▲ 0% | 415K▲ 110.9% | 3.52M▲ 749.4% | 8.83M▲ 150.4% | 2.82M▼ 68.1% | 1.65M▼ 41.3% | 4.09M▲ 147.2% | 6.89M▲ 68.6% | 11.92M▲ 73.0% | 12.89M▲ 0% |
Operating Margin % | -5.36% | 0.62% | 4.35% | 9.06% | 2.75% | 1.5% | 3.25% | 5.11% | 8.31% | 9.05% |
Operating Income Growth % | -491.38% | 110.89% | 749.4% | 150.41% | -68.05% | -41.35% | 147.16% | 68.57% | 72.98% | - |
EBITDA | 8.71M | 11.72M | 15.87M | 22.85M | 17.45M | 15.01M | 16.6M | 19.39M | 25.21M | 26.12M |
EBITDA Margin % | 12.26% | 17.46% | 19.56% | 23.46% | 17.04% | 13.66% | 13.19% | 14.38% | 17.58% | 18.34% |
EBITDA Growth % | -25.66% | 34.58% | 35.35% | 44.02% | -23.66% | -13.94% | 10.54% | 16.84% | 30.04% | 22.78% |
D&A (Non-Cash Add-back) | 12.52M | 11.31M | 12.34M | 14.03M | 14.63M | 13.36M | 12.51M | 12.5M | 13.29M | 13.23M |
EBIT | -3.92M | 378K | 3.43M | 8.8M | 2.63M | 1.53M | 4.02M | 7.53M | 11.92M | 13.05M |
Net Interest Income | -1.33M | -1.42M | -1.9M | -1.25M | -1.38M | -1.4M | -2.17M | -1.78M | -1.3M | -840K |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 1.33M | 1.42M | 1.9M | 1.25M | 1.38M | 1.4M | 2.17M | 1.78M | 1.3M | 840K |
Other Income/Expense | -1.45M | -1.46M | -2M | -1.28M | -1.56M | -1.52M | -2.24M | -1.83M | -1.3M | -1.1M |
Pretax Income | -5.26M▲ 0% | -1.04M▲ 80.2% | 1.52M▲ 246.3% | 7.54M▲ 394.9% | 1.26M▼ 83.3% | 130K▼ 89.7% | 1.85M▲ 1323.8% | 5.06M▲ 173.3% | 10.62M▲ 110.0% | 11.79M▲ 0% |
Pretax Margin % | -7.4% | -1.55% | 1.88% | 7.75% | 1.23% | 0.12% | 1.47% | 3.75% | 7.41% | 8.28% |
Income Tax | 15.45M | 53K | 163K | -9.79M | -163K | 112K | 979K | 2.71M | 4M | 3.88M |
Effective Tax Rate % | -293.89% | -5.09% | 10.7% | -129.78% | -12.97% | 86.15% | 52.89% | 53.65% | 37.62% | 32.88% |
Net Income | -20.71M▲ 0% | -1.09M▲ 94.7% | 1.36M▲ 224.3% | 17.33M▲ 1173.5% | 1.42M▼ 91.8% | 18K▼ 98.7% | 872K▲ 4744.4% | 2.35M▲ 168.9% | 6.63M▲ 182.6% | 7.91M▲ 0% |
Net Margin % | -29.13% | -1.63% | 1.68% | 17.8% | 1.39% | 0.02% | 0.69% | 1.74% | 4.62% | 5.56% |
Net Income Growth % | -9227.48% | 94.71% | 224.29% | 1173.48% | -91.81% | -98.73% | 4744.44% | 168.92% | 182.6% | 147.99% |
Net Income (Continuing) | -20.71M | -1.09M | 1.36M | 17.33M | 1.42M | 18K | 872K | 2.35M | 6.63M | 7.91M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.91▲ 0% | -0.05▲ 94.4% | 0.07▲ 227.8% | 0.80▲ 1125.1% | 0.06▼ 92.5% | 0.00▼ 98.7% | 0.04▲ 4900.0% | 0.11▲ 175.0% | 0.31▲ 181.8% | 0.38▲ 0% |
EPS Growth % | - | 94.38% | 227.79% | 1125.11% | -92.5% | -98.67% | - | 175% | 181.82% | 162.63% |
EPS (Basic) | -0.91 | -0.05 | 0.07 | 0.86 | 0.07 | 0.00 | 0.04 | 0.11 | 0.32 | - |
Diluted Shares Outstanding | 22.74M | 21.42M | 20.84M | 21.72M | 22.05M | 21.55M | 21.65M | 21.71M | 21.1M | 20.89M |
Basic Shares Outstanding | 22.74M | 21.42M | 19.73M | 20.11M | 20.52M | 20.65M | 21.02M | 21.27M | 20.66M | 20.21M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
INFU Balance Sheet
InfuSystem Holdings, Inc. (INFU) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 17.67M | 17.54M | 19.3M | 29.77M | 22.07M | 24.78M | 30.62M | 32.16M | 36.34M | 36.66M |
Cash & Short-Term Investments | 3.47M | 4.32M | 2.65M | 9.65M | 186K | 165K | 231K | 527K | 3.19M | 2.11M |
Cash Only | 3.47M | 4.32M | 2.65M | 9.65M | 186K | 165K | 231K | 527K | 3.19M | 2.11M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 11.28M | 9.59M | 12.1M | 14.72M | 15.4M | 16.87M | 19.83M | 21.16M | 22.9M | 23.98M |
Days Sales Outstanding | 57.95 | 52.15 | 54.43 | 55.17 | 54.92 | 56.02 | 57.54 | 57.26 | 58.28 | 61.3 |
Inventory | 1.76M | 2.25M | 2.9M | 3M | 3.94M | 4.82M | 6.4M | 6.53M | 5.39M | 5.83M |
Days Inventory Outstanding | 23.23 | 29.26 | 30.91 | 28.36 | 32.79 | 35.65 | 37.28 | 36.97 | 31.16 | 33.31 |
Other Current Assets | 1.15M | 1.37M | 1.66M | 2.4M | 2.54M | 2.92M | 4.16M | 3.96M | 4.86M | 4.74M |
Total Non-Current Assets | 51.21M | 46.54M | 59.92M | 67.22M | 75.52M | 74.61M | 72.3M | 71.45M | 64.22M | 61.99M |
Property, Plant & Equipment | 25M | 24.93M | 42.99M | 44.37M | 48.63M | 48M | 45.95M | 9.4M | 7.54M | 7.06M |
Fixed Asset Turnover | 2.84x | 2.69x | 1.89x | 2.20x | 2.11x | 2.29x | 2.74x | 14.34x | 19.03x | 8.34x |
Goodwill | 0 | 0 | 0 | 0 | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M |
Intangible Assets | 24.51M | 19.86M | 15.46M | 11.18M | 10.93M | 8.44M | 7.45M | 6.46M | 6.87M | 6.66M |
Long-Term Investments | -62K | 0 | 0 | 0 | 41.97M | 44.2M | 0 | 44.54M | 0 | 0 |
Other Non-Current Assets | 1.7M | 1.74M | 1.46M | 1.71M | -39.76M | -39.37M | 6.07M | 151K | 41.47M | 40.34M |
Total Assets | 68.88M▲ 0% | 64.07M▼ 7.0% | 79.22M▲ 23.6% | 96.99M▲ 22.4% | 97.59M▲ 0.6% | 99.39M▲ 1.8% | 102.92M▲ 3.5% | 103.61M▲ 0.7% | 100.56M▼ 2.9% | 98.66M▲ 0% |
Asset Turnover | 1.03x | 1.05x | 1.02x | 1.00x | 1.05x | 1.11x | 1.22x | 1.30x | 1.43x | 1.43x |
Asset Growth % | -28.51% | -6.98% | 23.65% | 22.43% | 0.61% | 1.85% | 3.55% | 0.68% | -2.95% | -21.51% |
Total Current Liabilities | 12.47M | 14.79M | 21.85M | 23M | 12.9M | 14.47M | 15.71M | 17.66M | 20.18M | 17.14M |
Accounts Payable | 5.52M | 7.09M | 7.96M | 6.78M | 7.86M | 8.34M | 8.01M | 9.85M | 10.82M | 9.63M |
Days Payables Outstanding | 72.64 | 92.04 | 84.89 | 64.05 | 65.45 | 61.69 | 46.64 | 55.77 | 62.55 | 58.96 |
Short-Term Debt | 3.54M | 4.94M | 8.08M | 9.42M | 349K | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 9.63M | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2.91M | 2.73M | 5.8M | 6.79M | 4.68M | -6.8M | 7.7M | 7.81M | 9.36M | 7.51M |
Current Ratio | 1.42x | 1.19x | 0.88x | 1.29x | 1.71x | 1.71x | 1.95x | 1.82x | 1.80x | 2.14x |
Quick Ratio | 1.27x | 1.03x | 0.75x | 1.16x | 1.41x | 1.38x | 1.54x | 1.45x | 1.53x | 1.80x |
Cash Conversion Cycle | 8.54 | -10.63 | 0.45 | 19.47 | 22.26 | 29.99 | 48.18 | 38.46 | 26.89 | 35.65 |
Total Non-Current Liabilities | 25.45M | 28.84M | 35.04M | 33.24M | 36.42M | 36.92M | 34.9M | 28.42M | 23.05M | 22.77M |
Long-Term Debt | 25.35M | 28.84M | 30.3M | 29.38M | 32.75M | 33.16M | 29.1M | 23.86M | 3.43M | 22.77M |
Capital Lease Obligations | 33K | 0 | 4.64M | 3.86M | 3.67M | 3.76M | 5.8M | 4.56M | 0 | 4.11M |
Deferred Tax Liabilities | 62K | 0 | 104K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.63M | 0 |
Total Liabilities | 37.93M | 43.63M | 56.89M | 56.24M | 49.31M | 51.38M | 50.61M | 46.09M | 43.23M | 39.91M |
Total Debt | 29.43M | 33.78M | 43.02M | 42.66M | 36.77M | 36.92M | 34.9M | 28.42M | 3.43M | 22.77M |
Net Debt | 25.96M | 29.46M | 40.37M | 33.02M | 36.58M | 36.75M | 34.67M | 27.9M | 241K | 20.66M |
Debt / Equity | 0.95x | 1.65x | 1.93x | 1.05x | 0.76x | 0.77x | 0.67x | 0.49x | 0.06x | 0.39x |
Debt / EBITDA | 3.38x | 2.88x | 2.71x | 1.87x | 2.11x | 2.46x | 2.10x | 1.47x | 0.14x | 0.87x |
Net Debt / EBITDA | 2.98x | 2.51x | 2.54x | 1.44x | 2.10x | 2.45x | 2.09x | 1.44x | 0.01x | 0.79x |
Interest Coverage | -2.95x | 0.27x | 1.80x | 7.01x | 1.91x | 1.09x | 1.85x | 4.24x | 9.18x | 15.54x |
Total Equity | 30.95M▲ 0% | 20.44M▼ 34.0% | 22.33M▲ 9.3% | 40.75M▲ 82.5% | 48.27M▲ 18.5% | 48M▼ 0.6% | 52.3M▲ 9.0% | 57.53M▲ 10.0% | 57.33M▼ 0.4% | 58.75M▲ 0% |
Equity Growth % | -38.94% | -33.96% | 9.26% | 82.47% | 18.45% | -0.56% | 8.96% | 9.99% | -0.35% | 8.06% |
Book Value per Share | 1.36 | 0.95 | 1.07 | 1.88 | 2.19 | 2.23 | 2.42 | 2.65 | 2.72 | 2.81 |
Total Shareholders' Equity | 30.95M | 20.44M | 22.33M | 40.75M | 48.27M | 48M | 52.3M | 57.53M | 57.33M | 58.75M |
Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K |
Retained Earnings | -61.63M | -62.73M | -61.37M | -44.03M | -53.9M | -59.34M | -58.63M | -57.46M | -60.7M | -60.54M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -38.57M | -42.02M | 0 | 0 | 268K | 1.49M | 1.09M | 1.12M | 565K | 575K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
INFU Cash Flow Statement
InfuSystem Holdings, Inc. (INFU) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 7.58M | 11.39M | 13.88M | 20.28M | 18.32M | 17.52M | 11.22M | 20.46M | 24.41M | 23.6M |
Operating CF Margin % | 10.67% | 16.97% | 17.11% | 20.82% | 17.89% | 15.94% | 8.92% | 15.17% | 17.02% | - |
Operating CF Growth % | -4.12% | 50.22% | 21.81% | 46.16% | -9.68% | -4.36% | -35.93% | 82.3% | 19.3% | 134.19% |
Net Income | -20.71M | -1.09M | 1.36M | 17.33M | 1.42M | 18K | 872K | 2.35M | 6.63M | 7.91M |
Depreciation & Amortization | 12.52M | 11.31M | 12.34M | 14.03M | 14.63M | 13.36M | 12.51M | 12.5M | 13.29M | 13.25M |
Stock-Based Compensation | 682K | 957K | 997K | 2.61M | 6.4M | 3.83M | 4.07M | 4.46M | 4.36M | 3.25M |
Deferred Taxes | 15.39M | -62K | 104K | -10.07M | -153K | 19K | 633K | 1.92M | 2.73M | 1.76M |
Other Non-Cash Items | 5.07M | 5.23M | -741K | -2.35M | -1.29M | -90K | -1.3M | -1.42M | -2.51M | 81K |
Working Capital Changes | -5.38M | -4.95M | -188K | -1.26M | -2.69M | 385K | -5.56M | 652K | -94K | -2.66M |
Change in Receivables | -5.45M | -4.41M | -1.56M | -2.63M | 829K | -1.15M | -2.36M | -701K | 263K | 108K |
Change in Inventory | 402K | -490K | -645K | -102K | -864K | -882K | -1.58M | -126K | 1.14M | 504K |
Change in Payables | -352K | 183K | 2.44M | 2.39M | -2.36M | 2.94M | 2.42M | -676K | -708K | -2.06M |
Cash from Investing | 1.05M | -4.98M | -19.64M | -12.16M | -21.32M | -11.48M | -6.73M | -13.24M | -6.79M | -5.39M |
Capital Expenditures | -3.6M | -8.3M | -22.59M | -16.91M | -16.66M | -15.08M | -11.12M | -1.09M | -560K | -3.3M |
CapEx % of Revenue | 5.06% | 12.37% | 27.86% | 17.37% | 16.27% | 13.72% | 8.84% | 0.81% | 0.39% | 2.31% |
Acquisitions | 3.87M | 3.32M | 2.95M | 4.75M | -7.98M | 3.6M | 0 | 0 | -1.41M | 993K |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 4.65M | 3.32M | 0 | 0 | 3.32M | 3.6M | 4.38M | -12.15M | -4.82M | -1.03M |
Cash from Financing | -8.56M | -5.56M | 4.1M | -1.12M | -6.46M | -6.06M | -4.42M | -6.92M | -14.96M | -17.61M |
Debt Issued (Net) | -8.6M | 4.84M | 4.57M | 407K | -5.47M | -13K | -3.95M | -5.32M | -4.32M | -9.13M |
Equity Issued (Net) | -58K | -10.46M | -717K | -1.71M | -1.73M | -6.65M | -1.31M | -2M | -10.64M | -8.46M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -58K | -10.46M | -717K | -1.71M | -1.73M | -6.65M | -1.31M | -2M | -10.97M | -8.82M |
Other Financing | 93K | 64K | 246K | 190K | 738K | 605K | 835K | 387K | 0 | -12K |
Net Change in Cash | 71K▲ 0% | 849K▲ 1095.8% | -1.67M▼ 296.8% | 7M▲ 519.0% | -9.46M▼ 235.2% | -21K▲ 99.8% | 66K▲ 414.3% | 296K▲ 348.5% | 2.66M▲ 798.3% | 600K▲ 0% |
Free Cash Flow | 3.99M▲ 0% | 3.09M▼ 22.6% | -8.72M▼ 382.4% | 3.37M▲ 138.6% | 1.66M▼ 50.7% | 2.44M▲ 47.0% | 106K▼ 95.7% | 2.63M▲ 2377.4% | 23.85M▲ 808.1% | 20.3M▲ 0% |
FCF Margin % | 5.61% | 4.6% | -10.75% | 3.46% | 1.62% | 2.22% | 0.08% | 1.95% | 16.63% | 14.26% |
FCF Growth % | 550.11% | -22.57% | -382.38% | 138.6% | -50.68% | 47.05% | -95.66% | 2377.36% | 808.15% | 57.67% |
FCF per Share | 0.18 | 0.14 | -0.42 | 0.15 | 0.08 | 0.11 | 0.00 | 0.12 | 1.13 | 0.97 |
FCF Conversion (FCF/Net Income) | -0.37x | -10.40x | 10.19x | 1.17x | 12.90x | 973.17x | 12.87x | 8.72x | 3.68x | 2.57x |
Interest Paid | 1.2M | 1.38M | 1.71M | 1.21M | 1.11M | 1.31M | 2.05M | 1.75M | 0 | 0 |
Taxes Paid | 139K | 159K | 111K | 102K | 171K | 153K | 213K | 753K | 0 | 0 |
INFU Key Ratios
InfuSystem Holdings, Inc. (INFU) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -50.73% | -4.26% | 6.36% | 54.95% | 3.19% | 0.04% | 1.74% | 4.27% | 11.54% | 14% |
Return on Invested Capital (ROIC) | -4.04% | 0.58% | 4.7% | 9.7% | 2.67% | 1.46% | 3.57% | 6% | 12.5% | 12.87% |
Gross Margin | 61.01% | 58.12% | 57.8% | 60.33% | 57.17% | 55.1% | 50.17% | 52.2% | 55.98% | 56.75% |
Net Margin | -29.13% | -1.63% | 1.68% | 17.8% | 1.39% | 0.02% | 0.69% | 1.74% | 4.62% | 5.56% |
Debt / Equity | 0.95x | 1.65x | 1.93x | 1.05x | 0.76x | 0.77x | 0.67x | 0.49x | 0.06x | 0.39x |
Interest Coverage | -2.95x | 0.27x | 1.80x | 7.01x | 1.91x | 1.09x | 1.85x | 4.24x | 9.18x | 15.54x |
FCF Conversion | -0.37x | -10.40x | 10.19x | 1.17x | 12.90x | 973.17x | 12.87x | 8.72x | 3.68x | 2.57x |
Revenue Growth | 0.82% | -5.54% | 20.82% | 20.06% | 5.13% | 7.36% | 14.44% | 7.22% | 6.36% | 3.5% |
Related:INFU Dividend History·INFU Revenue History·INFU Price History·INFU P/E History·INFU Financial Ratios·INFU Institutional Holders
INFU SEC Filings & Documents
InfuSystem Holdings, Inc. (INFU) SEC filings — annual & quarterly reports (10-K, 10-Q)
INFU Frequently Asked Questions
InfuSystem Holdings, Inc. (INFU) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
InfuSystem Holdings, Inc. (INFU) reported $142.4M in revenue for fiscal year 2025.
InfuSystem Holdings, Inc. (INFU) grew revenue by 6.4% over the past year. This is steady growth.
Yes, InfuSystem Holdings, Inc. (INFU) is profitable, generating $7.9M in net income for fiscal year 2025 (4.6% net margin).
Dividend & Returns
InfuSystem Holdings, Inc. (INFU) has a return on equity (ROE) of 11.5%. This is reasonable for most industries.
InfuSystem Holdings, Inc. (INFU) generated $20.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.